当前位置:首页 - 行情中心 - 金石亚药(300434) - 财务分析 - 利润表

金石亚药

(300434)

  

流通市值:27.99亿  总市值:32.86亿
流通股本:3.42亿   总股本:4.02亿

利润表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、营业总收入756,645,811.15521,930,079.53362,785,115.791,209,199,438.06
营业收入756,645,811.15521,930,079.53362,785,115.791,209,199,438.06
二、营业总成本670,119,991.15454,037,885.74247,274,368.45958,207,145.35
营业成本337,593,894.03225,155,874.87140,822,731.84466,915,362.63
税金及附加13,289,533.39,391,663.235,298,537.6422,989,650
销售费用172,290,852.34121,141,392.5354,552,466.55262,895,365.82
管理费用118,903,992.7580,784,582.539,529,763.1166,938,485.28
研发费用30,034,741.219,863,344.158,503,028.0850,011,112.66
财务费用-1,993,022.47-2,298,971.54-1,432,158.76-11,542,831.04
其中:利息费用1,008,743.17706,334.7232,908.93671,747.56
其中:利息收入3,366,004.222,809,175.471,575,982.1112,091,408.87
加:公允价值变动收益1,625,273.55679,867.08--
加:投资收益-8,030,294.51-5,479,602.64-2,639,662.66-18,427,831.35
资产处置收益6,163.416,117.6712,227.4250,297.58
资产减值损失(新)-852,265.13-863,901.4522,129.06-67,771,974.17
信用减值损失(新)-3,167,062.79-3,192,105.99-119,669.344,461,667.37
其他收益12,925,282.96,268,927.332,263,152.318,434,727.6
营业利润平衡项目0000
四、营业利润89,032,917.4365,311,495.79115,048,924.11177,939,179.74
加:营业外收入1,159,656.931,098,735.821,051,323.6660,858.91
减:营业外支出7,495,058.725,105,508.6531,654.881,582,695.33
利润总额平衡项目0000
五、利润总额82,697,515.6461,304,723.01115,568,592.83177,017,343.32
减:所得税费用26,816,959.723,330,120.1426,024,942.5256,305,726.16
六、净利润55,880,555.9437,974,602.8789,543,650.31120,711,617.16
持续经营净利润55,880,555.9437,974,602.8789,543,650.31120,711,617.16
终止经营净利润--0-
归属于母公司股东的净利润58,129,095.9639,202,246.6889,816,224.68126,199,723.64
少数股东损益-2,248,540.02-1,227,643.81-272,574.37-5,488,106.48
(一)基本每股收益0.140.10.220.31
(二)稀释每股收益0.140.10.220.31
九、综合收益总额55,880,555.9437,974,602.8789,543,650.31120,711,617.16
归属于母公司股东的综合收益总额58,129,095.9639,202,246.6889,816,224.68126,199,723.64
归属于少数股东的综合收益总额-2,248,540.02-1,227,643.81-272,574.37-5,488,106.48
公告日期2024-10-242024-08-292024-04-262024-04-26
审计意见(境内)标准无保留意见
TOP↑